EA
MYOK

Emerald Acquisition’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Emerald Acquisition’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$634K Buy
+38,792
New +$700K ﹤0.01% 2352

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's MYOK Position: Q3 2016 in Review

Emerald Acquisition opened a new position in MyoKardia, Inc. Common Stock (MYOK) in Q3 2016: 38,792 shares worth $634K. The stake represents ﹤0.01% of the portfolio and ranks #2352 among its holdings.

63 funds tracked by Wall St. Rank hold MYOK as of Q3 2016.

  • Emerald Acquisition held 38,792 shares of MyoKardia, Inc. Common Stock worth $634K as of Q3 2016.
  • MyoKardia, Inc. Common Stock was a new Emerald Acquisition position in Q3 2016.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2352 holding.
  • 63 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.